Company / EPS (Diluted)
Natera, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$3.78
FY2025
5-year range
-$5.57 / -$1.79
FY2021-FY2025
Trend
+32.1%
vs FY2024
Sector context
#145 of 159
Health Care
What the data says
Among 159 Health Care companies, Natera, Inc. is in the bottom 9% for eps (diluted). EPS (Diluted) returned to growth in FY2025 after 3 years of decline, reaching $-3.78.
Based on SEC 10-K filings.
-3.78 in FY2025.
Improved from $-5.21 to $-3.78 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 159This company -$3.78 Sector average $1.67
▼
-326.6% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 32.1% year-over-year.
- Ranks #145 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.78 | +32.1% |
| FY2024 | -$5.57 | -6.9% |
| FY2023 | -$5.21 | -83.5% |
| FY2022 | -$2.84 | -58.7% |
| FY2021 | -$1.79 | +19.4% |
| FY2020 | -$2.22 | +14.3% |
| FY2019 | -$2.59 | -32.8% |
| FY2018 | -$1.95 | +27.2% |
| FY2017 | -$2.68 | -150.5% |
| FY2016 | -$1.07 | +88.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026